98%
921
2 minutes
20
Three new species of the extinct spider genus †Furcembolus Wunderlich, 2008 from Late Cretaceous Burmese amber are described: Furcembolus chuandiani Jiang Li spec. nov., F. fengzheni Jiang Li spec. nov. and F. martensi Jiang Li spec. nov. All types are deposited in the Institute of Zoology, Chinese Academy of Sciences in Beijing, China.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11646/zootaxa.4984.1.19 | DOI Listing |
Sci Adv
June 2025
Institute of Ecology and State Key Laboratory for Vegetation Structure, Function and Construction (VegLab), College of Urban and Environmental Sciences, Peking University, Beijing, China.
Unraveling the mechanisms underlying the maintenance of species diversity is a central pursuit in ecology. It has been hypothesized that ectomycorrhizal (EcM) in contrast to arbuscular mycorrhizal fungi can reduce tree species diversity in local communities, which remains to be tested at the global scale. To address this gap, we analyzed global forest inventory data and revealed that the relationship between tree species richness and EcM tree proportion varied along environmental gradients.
View Article and Find Full Text PDFLancet Reg Health West Pac
May 2025
Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, China.
Background: The surge of group A (GAS) infections in regional countries warranted attention in the post-COVID-19 era. The resurgence of notifiable scarlet fever in China has been a public health issue since 2011. We conducted a consecutive 14-year surveillance study to analyse dynamic epidemiological profiles of scarlet fever from the perspective of epidemic trend and molecular evolution of GAS strains.
View Article and Find Full Text PDFJ Manag Care Spec Pharm
May 2025
Calliditas NA Enterprises, Inc., New York, NY.
Background: Immunoglobulin A nephropathy (IgAN) is a rare autoimmune disease that often leads to end-stage renal disease. The goal of treatment is to reduce disease progression so that patients are less likely to develop kidney failure in their natural lifetime. Recent clinical trial results show that Tarpeyo, a targeted-release formulation of budesonide designed to deliver the drug directly to gut-associated lymphoid tissue, reduces estimated glomerular filtration rate loss, potentially modifying the disease and thus prolonging the time to kidney failure.
View Article and Find Full Text PDFBackground: Direct oral anticoagulants (DOACs) are used to prevent thrombosis in patients with nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE). Despite their clinical benefits, some patients abandon their DOAC prescription.
Objective: To retrospectively evaluate the association between patient out-of-pocket (OOP) costs and abandonment of the first DOAC prescription among patients with NVAF or VTE in the United States.
Eur J Protistol
October 2024
The Key Laboratory of Zoological Systematics and Application, College of Life Sciences, Hebei University, Baoding 071002, China. Electronic address: